• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验模型中抗炎药物的心脏后果。

Cardiac consequences of anti-inflammatory drugs in experimental models.

作者信息

Merlet Nolwenn, Busseuil David, Rhéaume Éric, Tardif Jean-Claude

机构信息

Montreal Heart Institute, Research Center, 5000 Belanger Est, Montreal, QC, Canada.

出版信息

Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):24-35. doi: 10.2174/1871523011312010005.

DOI:10.2174/1871523011312010005
PMID:23286290
Abstract

Although heart failure is predominantly caused by cardiovascular conditions such as hypertension, coronary heart disease and valvular heart disease, it can also be caused by adverse drug reactions. Several medications have been shown to have cardiotoxic effects. Among those therapeutic agents, anti-inflammatory drugs, including exogenous glucocorticoids, nonsteroidal anti-inflammatory drugs and biologics, which are used to treat a broad range of diseases that are associated with inflammatory processes, are widely prescribed in clinical practice. In this review, we discuss insights from experimental models on the beneficial and cardiotoxic effects of anti-inflammatory drugs.

摘要

尽管心力衰竭主要由心血管疾病如高血压、冠心病和心脏瓣膜病引起,但也可能由药物不良反应导致。已有几种药物被证明具有心脏毒性作用。在这些治疗药物中,抗炎药,包括外源性糖皮质激素、非甾体抗炎药和生物制剂,用于治疗与炎症过程相关的多种疾病,在临床实践中被广泛使用。在本综述中,我们讨论了来自实验模型的关于抗炎药有益和心脏毒性作用的见解。

相似文献

1
Cardiac consequences of anti-inflammatory drugs in experimental models.实验模型中抗炎药物的心脏后果。
Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):24-35. doi: 10.2174/1871523011312010005.
2
[Problems in symptomatic therapy of rheumatic diseases with glucocorticoids and nonsteroidal antirheumatic agents].[糖皮质激素和非甾体类抗风湿药治疗风湿性疾病的对症治疗问题]
Internist (Berl). 1979 Sep;20(9):414-25.
3
Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.改善炎症性肺病中糖皮质激素疗效和治疗比率的药理学策略。
Pharmacol Ther. 2010 Feb;125(2):286-327. doi: 10.1016/j.pharmthera.2009.11.003. Epub 2009 Nov 22.
4
An overview of the adverse reactions to adrenal corticosteroids.肾上腺皮质类固醇不良反应概述。
Adverse Drug React Toxicol Rev. 1996 Nov;15(4):203-6.
5
Glucocorticoids.糖皮质激素。
Best Pract Res Clin Rheumatol. 2011 Dec;25(6):891-900. doi: 10.1016/j.berh.2011.11.002.
6
[Glucocorticoids and their receptor: mechanisms of action and clinical implications].[糖皮质激素及其受体:作用机制与临床意义]
Rev Med Interne. 2004 Sep;25(9):636-47. doi: 10.1016/j.revmed.2004.01.012.
7
[The dermocorticoids, irreplaceable and feared].[皮质类固醇,不可替代且令人畏惧]
Rev Med Suisse. 2014 Apr 9;10(425):821-6.
8
The search for safer glucocorticoid receptor ligands.寻找更安全的糖皮质激素受体配体。
Endocr Rev. 2005 May;26(3):452-64. doi: 10.1210/er.2005-0002. Epub 2005 Apr 6.
9
Cardiovascular adverse effects of anti-inflammatory drugs.抗炎药物的心血管不良反应。
Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):55-67. doi: 10.2174/1871523011312010008.
10
Current issues of basic and clinical glucocorticoid research.糖皮质激素基础与临床研究的当前问题
Clin Exp Rheumatol. 2003 Mar-Apr;21(2):145-7.

引用本文的文献

1
Glucocorticoid signaling in the heart: A cardiomyocyte perspective.心脏中的糖皮质激素信号传导:心肌细胞视角
J Steroid Biochem Mol Biol. 2015 Sep;153:27-34. doi: 10.1016/j.jsbmb.2015.03.009. Epub 2015 Mar 21.
2
N'-[(E)-2-Chloro-benzyl-idene]-2-(6-meth-oxy-naphthalen-2-yl)propano-hydrazide.N'-[(E)-2-氯-亚苄基]-2-(6-甲氧基-萘-2-基)丙酰肼
Acta Crystallogr Sect E Struct Rep Online. 2014 May 3;70(Pt 6):o631-2. doi: 10.1107/S1600536814008629. eCollection 2014 Jun 1.
3
N'-[(E)-Benzyl-idene]-2-(6-meth-oxy-naphthalen-2-yl)propano-hydrazide.
N'-[(E)-苄叉基]-2-(6-甲氧基萘-2-基)丙酰肼
Acta Crystallogr Sect E Struct Rep Online. 2013 Oct 5;69(Pt 11):o1614. doi: 10.1107/S1600536813026986.